新版GSP背景下第三方医药物流行业的发展策略  

Development Strategy under the New GSP Context of Third-party Pharmaceutical Logistics Industry

作　　者：康传哲[1] 桑纳 张方[1] 朱龙社[1] 韩玉霞[1] 何志龙 

机构地区：[1]中国人民解放军第四五二医院,成都611830 [2]贵州省毕节医学高等专科学校,毕节551700

出　　处：《中国药事》2017年第2期130-133,共4页Chinese Pharmaceutical Affairs

摘　　要：目的:分析新版《药品经营质量管理规范》(GSP)正式实施后,我国第三方医药物流企业如何适应新形势、新要求,从而得到快速、健康发展。方法:通过态势分析(Strengths Weakness Opportunity Threats,SWOT)、政策研究、对比分析等方法,深入解析新版GSP与我国第三方医药物流的相关规定。结果:第三方医药物流企业的现状尚不适应新版GSP要求。结论:第三方医药物流企业应严格按照新版GSP要求进行改造升级,促进第三方医药物流健康、快速发展。Objective： To analyze how the third-party medical logistics enterprises in our country can adapt to the new situation and new requirements after the implementation of the new Drug-handling Quality Management Norms（GSP）, so as to get rapid and healthy development. Methods： Through the analysis of the situation（Strengths Weakness Opportunity Threats, SWOT）, policy research and contrast analysis, the new GSP and the relevant provisions of the third-party medical logistics in our country were studied. Results： At present, the thirdparty medical logistics enterprises in China has still not adapted to the new GSP requirements. Conclusion： The third-party medical logistics enterprises in China should be upgraded in strict accordance with the new GSP requirements, so as to promote the rapid and healthy development of the third-party medical logistics in our country.

关 键 词：新版药品经营质量管理规范 第三方医药物流 态式分析 医药流通行业标准 供应链管理 

分 类 号：R951[医药卫生—药学] R956.11